ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma

Summary: In glioblastoma (GBM), the most frequent and lethal brain tumor, therapies suppressing recurrently altered signaling pathways failed to extend survival. However, in patient subsets, specific genetic lesions can confer sensitivity to targeted agents. By exploiting an integrated model based o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Francesca De Bacco, Francesca Orzan, Jessica Erriquez, Elena Casanova, Ludovic Barault, Raffaella Albano, Antonio D’Ambrosio, Viola Bigatto, Gigliola Reato, Monica Patanè, Bianca Pollo, Geoffrey Kuesters, Carmine Dell’Aglio, Laura Casorzo, Serena Pellegatta, Gaetano Finocchiaro, Paolo M. Comoglio, Carla Boccaccio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-07-01
coleção:	Cell Reports
Assuntos:	glioblastoma ERBB3 HER3 miR-205 FGF cancer stem cell
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S221112472100872X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!